Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02596035
Title A Phase 3b/4 Safety Trial of Nivolumab (BMS-936558) in Subjects With Advanced or Metastatic Renal Cell Carcinoma (CheckMate 374)
Recruitment Active, not recruiting
Gender both
Phase FDA approved
Variant Requirements No
Sponsors Bristol-Myers Squibb

renal cell carcinoma



Age Groups: adult
Covered Countries USA

No variant requirements are available.